Atlas Trials

A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

Clinical trial NCT06202079 · COMPLETED

Trial details

NCT number
NCT06202079
Sponsor
Gan and Lee Pharmaceuticals, USA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2023-08-11
Primary completion
2024-07-13
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.